
|Videos|January 13, 2022
Mirvie RNA test aims to predict pregnancy complications
Author(s)Morgan Ebert, Managing Editor
Maneesh Jain, CEO and co-founder of Mirvie, a proprietary RNA platform that uses blood samples to predict pregnancy complications such as preeclampsia, sits down with Contemporary OB/GYN to discuss the potential of the test.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Minipad-based HPV testing shows promise for cervical cancer screening
2
Study data highlight trade-offs of testing for pregnancy too soon
3
Barbara Levy, MD, on importance of public comments on new cervical cancer screening guidance
4
Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy
5








